VIDEO: Yeu shares pearls on IOL exchange in postop refractive patients

NEW YORK — In this Healio Video Perspective from OSN New York, Elizabeth Yeu, MD, FACS, discusses IOL exchange for postoperative refractive patients, including when and why to consider it and potential alternatives.
“We are really discussing the realm of taking care of the refractive miss and how we are going to hit our targets postoperatively in the realm of doing IOL exchanges,” she said.

VIDEO: Netarsudil increases episcleral venous flow

CHICAGO — In this Healio Video Perspective from the AAO meeting, Osamah Saeedi, MD, discusses the effects of netarsudil on episcleral venous flow in subjects with ocular hypertension and glaucoma suspects.
According to Saeedi, the study showed significant increases in episcleral venous flow and diameter at 1 hour after treatment with Rhopressa (netarsudil ophthalmic solution 0.02%, Alcon/Aerie). These effects persisted at 1 week.

Tibia, blood epigenetic biomarkers of lead exposure tied to elevated CVD mortality risk

Higher levels of novel tibia and blood epigenetic biomarkers of lead exposure were associated with increased CVD mortality risk in American Indian men, researchers reported.
“This analysis builds on the development of bone and blood lead epigenetic biomarkers and is the first study to evaluate their relation with cardiovascular outcomes,” Wil Lieberman-Cribbin, MPH, PhD student at Columbia University, and colleagues wrote in the Journal of American Heart Association.
For the prospective cohort study, Lieberman-Cribbin and colleagues evaluated the relationship between epigenetic

Patient navigation reduces costs of care for patients with cancer in statewide health plan

Patient navigation programs have historically been difficult to implement on a large scale.
To help address this challenge, researchers investigated a scalable, independent program in collaboration with a large, statewide Medicare Advantage plan in New Jersey.
“There is a great deal of data out there showing that cancer navigation improves patient experience, lowers the cost of care and improves outcomes,” Bobby Green, MD, co-founder and president of Thyme Care, the developer of the navigation program, told Healio. “That was the reason for starting this company — we knew

ulrich Medical USA receives FDA 510(k) clearance of 3D-printed cervical interbody device

ulrich Medical USA Inc. has announced FDA 510(k) clearance of the Flux-C, a 3D-printed porous titanium cervical interbody device, according to a company press release.
The porous titanium component of the Flux-C device is designed with large graft windows to allow for improved radiographic imaging, according to the release.
“We are continuing to develop procedural solutions for reconstruction of all spinal pathologies in collaboration with our surgeon advisory board,” Eric Lucas, PhD, director of technology for ulrich Medical USA, said in the release. “We strive to help our